Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Toxicity × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 6 Neoplasms 5 Breast Neoplasms 4 Vomiting 2 Solid Tumors 2 Neoplasm Metastasis 2 Weight Gain 1 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Skin Toxicity 1 Skin Neoplasms 1 Renal Insufficiency 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Parathyroid Neoplasms 1 Nausea 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1

Interventions

Tablets 1 Doxycycline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03448731 2020-04-08

DERMIA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 2 Completed

Skin Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡